| For: | Zhang Z, Dai DQ. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation. World J Gastroenterol 2019; 25(10): 1224-1237 [PMID: 30886505 DOI: 10.3748/wjg.v25.i10.1224] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i10/1224.htm |
| Number | Citing Articles |
| 1 |
P Shereen Farhana, K P Ameya, P P Ashikha Shirin Usman, Durairaj Sekar. The impact of microRNA-596 on oral cancer: Insights into tumor biology and treatment strategies. Acta Marisiensis - Seria Medica 2025; 71(1) doi: 10.2478/amma-2025-0007
|
| 2 |
Ligong Fu, Huawei Liu, Weijun Lei. MiR-596 inhibits osteoblastic differentiation and cell proliferation by targeting Smad3 in steroid-induced osteonecrosis of femoral head. Journal of Orthopaedic Surgery and Research 2020; 15(1) doi: 10.1186/s13018-020-01688-5
|
| 3 |
Yang Huang, Zuo-Gang Wang, Liang Tang, Su-Gang Gong, Yuan-Yuan Sun, Lan Wang, Rong Jiang, Wen-Hui Wu, Ci-Jun Luo, Jie Zhang, Xiao-Jun Yang, Jin-Ling Li, Xun-Tao Yuan, Qin-Hua Zhao, Ping Yuan. Plasma exosomal miR-596: a novel biomarker predicts survival in patients with idiopathic pulmonary artery hypertension. Journal of International Medical Research 2021; 49(3) doi: 10.1177/03000605211002379
|
| 4 |
Jie Zhang, Keqing Shi, Weiguo Huang, Wanqing Weng, Zhongjing Zhang, Yangyang Guo, Tuo Deng, Yukai Xiang, Xiaofeng Ni, Bicheng Chen, Mengtao Zhou. The DNA methylation profile of non-coding RNAs improves prognosis prediction for pancreatic adenocarcinoma. Cancer Cell International 2019; 19(1) doi: 10.1186/s12935-019-0828-8
|
| 5 |
J. Dai, G. Yuan, Y. Li, H. Zhou. MicroRNA-596 is epigenetically inactivated and suppresses prostatic cancer cell growth and migration via regulating Wnt/β-catenin signaling. Clinical and Translational Oncology 2021; 23(7) doi: 10.1007/s12094-020-02536-y
|
| 6 |
Chun-hui Lai, Xu-zhi Liang, Xiu-yun Liang, Sheng-jun Ma, Jun-guo Li, Ming-fang Shi, Xu Zhu, Hui-hua Lan, Jiang-hui Zeng. Study on miRNAs in Pan-Cancer of the Digestive Tract Based on the Illumina HiSeq System Data Sequencing. BioMed Research International 2019; 2019 doi: 10.1155/2019/8016120
|
| 7 |
Zhou Zhang, Yujie Wang, Yuhao Liu, Haizhen Wu, Xiaopeng Xu, Kai Wang, Chen He, Chen Qian. Involvement of the PRDX family and its clinical functions in different types of gastrointestinal cancer (Review). Oncology Reports 2025; 54(2) doi: 10.3892/or.2025.8923
|
| 8 |
Hu Fen, Zheng Hongmin, Wei Wei, Yang Chao, Yao Yang, Liu Bei, Sun Zhihua. RHPN1-AS1 Drives the Progression of Hepatocellular Carcinoma via Regulating miR-596/IGF2BP2 Axis. Current Pharmaceutical Design 2020; 25(43) doi: 10.2174/1381612825666191105104549
|
| 9 |
Dong-Qiu Dai, Zhen Zhang. Correction to “MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation”. World Journal of Gastroenterology 2022; 28(43): 6203-6205 doi: 10.3748/wjg.v28.i43.6203
|
| 10 |
Sylwia Ciesielska, Izabella Slezak-Prochazka, Patryk Bil, Joanna Rzeszowska-Wolny. Micro RNAs in Regulation of Cellular Redox Homeostasis. International Journal of Molecular Sciences 2021; 22(11) doi: 10.3390/ijms22116022
|
| 11 |
Bashdar Mahmud Hussen, Hazha Jamal Hidayat, Abbas Salihi, Dana K. Sabir, Mohammad Taheri, Soudeh Ghafouri-Fard. MicroRNA: A signature for cancer progression. Biomedicine & Pharmacotherapy 2021; 138 doi: 10.1016/j.biopha.2021.111528
|
| 12 |
Jonathan K. L. Mak, Asmus Cosmos Skovgaard, Marianne Nygaard, Laura Kananen, Chandra A. Reynolds, Yunzhang Wang, Ralf Kuja‐Halkola, Ida K. Karlsson, Nancy L. Pedersen, Sara Hägg, Mette Soerensen, Juulia Jylhävä. Epigenome‐wide analysis of frailty: Results from two European twin cohorts. Aging Cell 2024; 23(6) doi: 10.1111/acel.14135
|
| 13 |
Deying Wang, Yulan Cui, Aili Xu, Lin Zhao, Peiling Li. MiR-596 activated by EP300 controls the tumorigenesis in epithelial ovarian cancer by declining BRD4 and KPNA4. Cancer Cell International 2020; 20(1) doi: 10.1186/s12935-020-01497-0
|
| 14 |
Ruixian Yu, Miao Zhang, Yan Meng, Chunxiao Zhu, Weihong Zhang, Hui Zhang, Zhifa Cao, Meihang Du, Zhangting Zhao, Junping Bai, Yi Han, Yang Tang, Wei Kang, Ka Fai To, Shi Jiao, Liwei An, Zhaocai Zhou. Gastric Cancer: Pathobiology and Therapeutics. MedComm 2026; 7(6) doi: 10.1002/mco2.70772
|
| 15 |
Yuxin He, Liangjian Zheng, Mengzhen Yuan, Jia Fan, Liwen Rong, Tingting Zhan, Jun Zhang. Exosomal circPRRX1 functions as a ceRNA for miR-596 to promote the proliferation, migration, invasion, and reduce radiation sensitivity of gastric cancer cells via the upregulation of NF-κB activating protein. Anti-Cancer Drugs 2022; 33(10) doi: 10.1097/CAD.0000000000001358
|
| 16 |
Xiwu Zhao, Jian Li, Dapeng Yu. MicroRNA-939-5p directly targets IGF-1R to inhibit the aggressive phenotypes of osteosarcoma through deactivating the PI3K/Akt pathway. International Journal of Molecular Medicine 2019; doi: 10.3892/ijmm.2019.4333
|
| 17 |
Bingli Wu, Yinwei Cheng, Liyan Li, Zepeng Du, Qianlou Liu, Xinyue Tan, Xin Li, Guozhi Zhao, Enmin Li. Role of the sulfur-containing amino acid-ROS axis in cancer chemotherapeutic drug resistance. Drug Resistance Updates 2025; 81 doi: 10.1016/j.drup.2025.101238
|